Etiflam 60/ 90/ 120 60/ 90/ 120 mg FC Tablet

Etiflam 60/ 90/ 120 60/ 90/ 120 mg FC Tablet

S3
PDF Leaflet Revision Date: 13 July 2023

API: Etoricoxib | Company: Cipla Medpro

Clinical Summary

Quick overview from the medicine insert

Indication

Symptomatic relief of rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, acute pain, primary dysmenorrhoea, and post-operative dental pain.

Dosage (summary)

90 mg once daily for RA and AS; 120 mg once daily for acute gout; 120 mg for primary dysmenorrhoea; 90 mg for post-operative pain.

Special Populations

  • Elderly
  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation; may cause uterine inertia and premature closure of ductus arteriosus.

Key Drug Interactions

  • Warfarin
  • Lithium
  • Diuretics
  • ACE inhibitors
  • Methotrexate

Contraindications

  • Hypersensitivity to etoricoxib
  • Active peptic ulceration
  • Severe hepatic insufficiency
  • Creatinine clearance < 30 mL/min
  • Uncontrolled hypertension
  • Children under 16

Common side effects

  • Hypertension
  • Dizziness
  • Gastrointestinal complications
  • Oedema
  • Headache

Counselling Points

  • Take with or without food
  • Use lowest effective dose for shortest duration
  • Monitor for signs of cardiovascular issues
  • Report any skin reactions immediately

Serious warnings

  • Increased risk of cardiovascular events
  • Gastrointestinal bleeding
  • Serious skin reactions
  • Fluid retention

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Etiflam 60/ 90/ 120 60/ 90/ 120 mg FC Tablet
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW